New Delhi [India], May 13 (ANI): Several vaccination centres where Covaxin is being administered in the national capital on Thursday remained closed for the age group of 18-44 years due to its non-availability.
New Delhi [India], May 13 (ANI): The National Technical Advisory Group on Immunisation (NTAGI) on Thursday recommended an increase in the gap between two doses of Serum Institute of India's COVISHIELD to 12-16 weeks.
New Delhi [India], May 13 (ANI): The Drugs Controller General of India (DCGI) on Thursday approved Phase 2 and 3 clinical trial of Bharat Biotech's COVAXIN vaccine in the age group of 2 to 18 years, informed the Ministry of Health and Family Welfare.
New Delhi [India], May 13 (ANI): No centre in the national capital will be able to administer COVID-19 vaccine 'Covaxin' from Thursday to the age group of 18-44 years due to unavailability of its stock, said Aam Aadmi Party (AAP) MLA Atishi Marlena on Wednesday.
New Delhi [India], May 12 (ANI): Delhi is left with 4,35,070 COVID vaccine doses in its balance stock out of which 16,900 doses are of Covaxin and 4,18,170 of Covishield reserved for the age group 18-44 years, informed the Delhi government.
New Delhi [India], May 12 (ANI): Amid the reports of shortage of Bharat Biotech's COVID-19 vaccine, the Centre on Wednesday said it will double the current production capacity of COVAXIN by May-June and then increase it to nearly six to seven folds by July-August. The government of India sai
New Delhi [India], May 12 (ANI): The Delhi government has been forced to shut down 100 vaccination sites over 17 schools that administered Bharat Biotech's COVAXIN vaccine due to a dearth of supply from the manufacturer, Delhi Deputy Chief Minister Manish Sisodia said on Wednesday.
New Delhi [India], May 12 (ANI): The Subject Expert Committee (SEC) has given a nod to Bharat Biotech's Covaxin for Phase 2 and 3 human clinical trials on children aged between two to eight years old, sources confirmed on Wednesday.
New Delhi [India], May 12 (ANI): Delhi Chief Minister Arvind Kejriwal on Tuesday wrote to Prime Minister Narendra Modi, requesting to allow other companies with "capabilities", to manufacture the two COVID-19 vaccines--Covaxin and Covishield--being already produced in India.
New Delhi [India], May 11 (ANI): Bharat Biotech on Tuesday informed that the firm has been supplying its COVID-19 vaccine Covaxin directly to 18 states since May 1.
Ludhiana (Punjab) [India], May 8 (ANI): The Ludhiana health department on Saturday issued a new schedule for administering Covaxin and Covishield vaccines,
Bengaluru (Karnataka) [India], May 8 (ANI): Karnataka Health Minister Dr K Sudhakar on Friday informed that the two sets of COVID vaccine available with the state - Covishield and Covaxin - will be administered on priority to people above the age of 45.